Yang, Fan
Liu, Pei
Meng, Xiangdan
Lu, Huiting
Cao, Yu
Dai, Wenhao
Wang, Changtao
Dong, Haifeng
Funding for this research was provided by:
Major Program of the National Natural Science Foundation of China (21890742)
Fundamental Research Funds for the Central Universities (FRF-BD-17-016A)
Special Foundation for State Major Research Program of China (2016YFC0106602)
Beijing Municipal Science and Technology Commission (z131102002813058)
Open Research Fund Program of Beijing Key Lab of Plant Resource Research and Development, Beijing Technology and Business University (PRRD-2016-YB2)
National Natural Science Foundation of China (21874008)
Article History
Received: 31 October 2018
Revised: 26 February 2019
Accepted: 4 March 2019
First Online: 11 April 2019
Compliance with ethical standards
: The MCF-7 cells (human breast cancer cells), HeLa cells (human cervical carcinoma cells), and NHDF cells (normal human dermal fibroblasts) were obtained from Beijing Dingguo Changsheng Biotechnology Co., Ltd. (Beijing, China). The animal experiments were approved by the Institutional Animal Care and Use Committee of the Beijing institute of Basic Medical Science (Beijing, Chain). The animal experiment was conducted in compliance with the National Regulation of China for the Care and Use of Laboratory Animals.
: Fan Yang and Pei Liu received research grants from the Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology and Business University. The authors declare that they have no conflict of interest.